Eagle Health Investments’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-99,634
Closed -$16.3M 23
2023
Q3
$16.3M Buy
99,634
+19,608
+25% +$4.63M 3.58% 13
2023
Q2
$26.3M Hold
80,026
4.91% 8
2023
Q1
$22.1M Sell
80,026
-1,348
-2% -$495K 4.3% 13
2022
Q4
$31.5M Sell
81,374
-1,159
-1% -$327K 7.27% 5
2022
Q3
$19.7M Buy
82,533
+14,602
+21% +$3.91M 4.53% 13
2022
Q2
$15.1M Buy
67,931
+45,998
+210% +$19.8M 3.53% 14
2022
Q1
$14.9M Hold
21,933
3.68% 15
2021
Q4
$15.2M Sell
21,933
-254
-1% -$188K 3.69% 13
2021
Q3
$16.5M Buy
22,187
+9,787
+79% +$6.67M 5.22% 8
2021
Q2
$9.3M Buy
12,400
+5,913
+91% +$4.52M 3.19% 16
2021
Q1
$5.29M Buy
6,487
+1,687
+35% +$1.3M 2.08% 18
2020
Q4
$4.09M Buy
+4,800
New +$3.7M 2.62% 17

Other funds holding OM

Eagle Health Investments's OM Position: Q4 2023 in Review

Eagle Health Investments sold out of Outset Medical (OM) in Q4 2023, closing a stake of 99,634 shares — an estimated $16.3M sold.

Eagle Health Investments first reported a position in OM in Q4 2020 and held it in 12 quarters. The position peaked at $31.5M in Q4 2022. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

  • Eagle Health Investments reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
  • Eagle Health Investments sold 99,634 Outset Medical shares in Q4 2023, an estimated $16.3M.
  • Eagle Health Investments first reported a position in Outset Medical in Q4 2020 and held it in 12 quarters.
  • Eagle Health Investments's Outset Medical position peaked at $31.5M in Q4 2022.
  • 140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Eagle Health Investments's 13F filing for Q4 2023, filed 12 Feb 2024.